Share This Article
Wearables are increasingly used in the healthcare sector with new eHealth applications launched every other day, but medical devices regulations might be the real obstacle to their growth.
Legal issues relating to the potential qualification of wearables as medical devices have become popular on the press following the presentation of the first smartphone with a heart rate sensor, quickly followed by the smartwatch and the smartbracelet with the same functionalities. ย During the same days UK authorities took an unexpected position on mobile apps aimed at controlling or monitor users’ health which might impact the Internet of Things sector.
The different approach between South Korea and the UK on wearables
The South Korea’s Ministry of Food and Drug Safety held that the smartphone was not subject to medical devices regulations adding that they plan to revise the current laws on the matter in order to distinguish between heart rate sensors used for leisure and those used for medical purposes. Indeed, the unusual position taken by the Korean Ministry was that the product is “technically” a medical device, but will be excluded from the category.ย
This very forward looking approach comes at the same time when the UK Medicines and Healthcare products Regulations Agency issued a guidance on medical device stand-alone software including appsย holding in particular that
“apps acting as accessories to medical devices such as in the measurement of temperature, heart rate, blood pressure and blood sugars could be a medical device“
Also adding that software providing “general information but does not provide personalised advice [—]ย is unlikely to be considered a medical device” so setting the field on which disputes as to the qualifications of software will take place.
What derives from the qualification of wearables as medical devices?
The consequence of the qualification of software or products (including wearables) as medical devices is that technology companies – which in relation to this type of technology already have to deal with considerable data protection issuesย – will have to face an additional obstacle given by compliance and approval obligations applicable to medical devices.
Also, product liability issues might arise in terms a damages claims that might be brought against companies manufacturing Apps to be used with such wearables and insurance policies that they will be obliged to put in place. Yet such obstacles might also slow down the introduction of future updates/upgrades should they go through the approval process required for medical devices so delaying the technological development.
Hopefully, the position adopted by the Korean authorities will be followed by other countries, but, in the current situation of uncertainty on the qualification of products collecting health related data, a prior analysis by the competent authorities or at least an expert in the field will be absolutely necessary.ย
Follow me on LinkedIn โย Facebook Page โย Twitter โย Telegram โ YouTubeย โ Google+